Symposia: Mantle Cell, Follicular, Waldenstrom’s, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Clinical trials, Combination therapy, Research, Adult, Lymphomas, Non-Hodgkin lymphoma, Elderly, Epidemiology, Clinical Research, B Cell lymphoma, Health outcomes research, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Diseases, Indolent lymphoma, Therapy sequence, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Registries, Study Population, Human, Measurable Residual Disease
Type: Oral
Hematology Disease Topics & Pathways:
Clinical trials, Combination therapy, Research, Adult, Lymphomas, Non-Hodgkin lymphoma, Elderly, Epidemiology, Clinical Research, B Cell lymphoma, Health outcomes research, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Diseases, Indolent lymphoma, Therapy sequence, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Registries, Study Population, Human, Measurable Residual Disease
Monday, December 9, 2024: 10:30 AM-12:00 PM
Marriott Grand Ballroom 8-9
(Marriott Marquis San Diego Marina)
Moderators:
Judith Trotman, FRACP, Concord Repatriation General Hospital
and
Akiva Diamond, MD, Baylor College of Medicine
Disclosures:
Trotman: Beigene: Research Funding; BMS: Research Funding; Cellectar: Research Funding; Janssen: Research Funding; Roche: Research Funding.
High impact abstracts related to the treatment of Mantle Cell Lymphoma and Hairy Cell leukemia
10:30 AM
10:45 AM
11:00 AM
11:15 AM
11:30 AM
11:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH